National AIDS Control Organization, “Anti-Retroviral Treatment: A New Initiative,” 2010. http://www.nacoonline.org/Quick_Links/Directory/directory_ARV/
 National AIDS Control Organization, “Prevention Strategies,” 2010. http://www.nacoonline.org/National_AIDS_Control_Program/Prevention_Strategies/
 R. N. Alves, M. J. Kovacs, R. Stall and V. Paiva, “Psychosocial Aspects of HIV Infection among Women in Brazil,” Revista de Saúde Pública, Vol. 36, No. 4, 2002, pp. 32-39. doi:10.1590/S0034-89102002000500006
 S. Floyd, A. C. Crampin, J. R. Glynn, M. Mwenebabu, S. Mnkhondia, B. Ngwira, B. Zaba and P. E. Fine, “The Long-Term Social and Economic Impact of HIV on the Spouses of Infected Individuals in Northern Malawi,” Tropical Medicine & International Health, Vol. 13, No. 4, 2008, pp. 520-531. doi:10.1111/j.1365-3156.2008.02030.x
 National AIDS Control Organization, “FAQs on Sexual and Reproductive Health,” 2010. http://www.nacoonline.org/Quick_Links/FAQs/
 K. Van Vaerenbergh, “Study of the Impact of HIV Genotypic Drug Resistance Testing on Therapy Efficacy,” Verhandelingen-Koninklijke Academie voor Geneeskunde van Belgi?, Vol. 63, No. 5, 2001, pp. 447-473.
 A. Palepu, M. W. Tyndall, K. Chan, E. Wood, J. S. Montaner and R. S. Hogg, “Initiating Highly Active Antiretroviral Therapy and Continuity of HIV Care: The Impact of Incarceration and Prison Release on Adherence and HIV Treatment Outcomes,” Antiviral Therapy, Vol. 9, No. 5, 2004, pp. 71371-71379.
 F. Gutierrez, S. Padilla, M. Masiá, et al., “Clinical Outcome of HIV-Infected Patients with Sustained Virologic Response to Antiretroviral Therapy: Long-Term Follow-Up of a Multicenter Cohort,” PLoS One, Vol. 20, No. 1, 2006, p. e89. doi:10.1371/journal.pone.0000089
 C. D. Evans, D. T. Eurich, D. A. Lamb, et al., “Retrospective Observational Assessment of Statin Adherence among Subjects Patronizing Different Types of Community Pharmacies in Canada,” Journal of Managed Care Pharmacy, Vol. 15, No. 6, 2009, pp. 4764-4784.
 J. B. Nachega, M. Hislop, D. W. Dowdy, et al., “Adherence to Nonnucleoside Reverse Transcriptase Inhibitor- Based HIV Therapy and Virologic Outcomes,” Annals of Internal Medicine, Vol. 146, No. 8, 2007, pp. 564-735
 A. M. Geretti, C. Smith, A. Haberl, et al., “Determinants of Virological Failure after Successful Viral Load Suppression in First-Line Highly Active Antiretroviral Therapy,” Antiviral Therapy, Vol. 13, No. 7, 2008, pp. 927- 936.
 S. C. Kalichman, M. DiMarco, J. Austin, W. Luke and K. DiFonzo, “Stress, Social Support, and HIV-Status Disclosure to Family and Friends among HIV-Positive Men and Women,” Journal of Behavioral Medicine, Vol. 26, No. 4, 2003, pp. 315-332. doi:10.1023/A:1024252926930
 L. Persson, B. Gullberg, B. S. Hanson, T. Moestrup and P. O. Ostergren, “HIV Infection: Social Network, Social Support, and CD4 Lymphocyte Values in Infected Homosexual Men in Malm?, Sweden,” Journal of Epidemiology & Community Health, Vol. 48, No. 6, 1994, pp. 580-585. doi:10.1136/jech.48.6.580
 L. V. Edwards, “Perceived Social Support and HIV/ AIDS Medication Adherence among African American Women,” Qualitative Health Research, Vol. 16, No. 5, 2006, pp. 679-691. doi:10.1177/1049732305281597
 D. O. Perkins, E. J. Davidson, J. Leserman, D. Liao and D. L. Evans, “Personality Disorder in Patients Infected with HIV: A Controlled Study with Implications for Clinical Care,” American Journal of Psychiatry, Vol. 150, No. 2, 1993, pp. 309-315.
 T. M. Wolf, P. M. Balson, et al., “Relationship of Coping Style to Affective State and Perceived Social Support in Asymptomatic and Symptomatic HIV-Infected Persons: Implications for Clinical Management,” Journal of Clinical Psychiatry, Vol. 52, No. 4, 1991, pp. 171-173.
 K. I. Pakenham and M. Rinaldis, “The Role of Illness, Resources, Appraisal, and Coping Strategies in Adjustment to HIV/AIDS: The Direct and Buffering Effects,” Journal of Behavioral Medicine, Vol. 24, No. 3, 2001, pp. 259-279. doi:10.1023/A:1010718823753
 P. Williams, L. Narciso, et al., “The Prevalence, Correlates, and Costs of Depression in People Living with HIV/AIDS in Ontario: Implications for Service Directions,” AIDS Education and Prevention, Vol. 17, No. 2, 2005, pp. 119-130. doi:10.1521/aeap.22.214.171.124903
 U. Sambamoorthi, J. Walkup, M. Olfson and S. Crystal, “Antidepressant Treatment and Health Services Utilization among HIV-Infected Medicaid Patients Diagnosed with Depression,” Journal of General Internal Medicine, Vol. 15, No. 5, 2000, pp. 311-320. doi:10.1046/j.1525-1497.2000.06219.x
 T. G. Heckman, J. Miller, et al., “Thoughts of Suicide among HIV-Infected Rural Persons Enrolled in a Telephone-Delivered Mental Health Intervention,” Annals of Behavioral Medicine, Vol. 24, No. 2, 2002, pp. 141-148. doi:10.1207/S15324796ABM2402_11
 A. Komiti, F. Judd, et al., “Suicidal Behaviour in People with HIV/AIDS: A Review,” Australian and New Zealand Journal of Psychiatry, Vol. 35, No. 6, 2001, pp. 747- 757. doi:10.1046/j.1440-1614.2001.00943.x
 N. A. Cooperman and J. M. Simoni, “Suicidal Ideation and Attempted Suicide among Women Living with HIV/AIDS,” Journal of Behavioral Medicine, Vol. 28, No. 2, 2005, pp. 149-156. doi:10.1007/s10865-005-3664-3